ALMS

Conviction 61HealthcareScan · Thu, Jun 25, 2026

ALMS$25.01+0.64%

ResistanceSupportVol 14

Vol MA14 1.47M

Mar 26Apr 14May 1May 19Jun 8Jun 25

ALUMIS INC.PHARMACEUTICAL PREPARATIONSwww.alumis.com ↗

Price25.01

Change+0.64%

Gap-1.05%

Rel volume1.21×

Avg volume1.36M

Avg $ vol29.78M

SMA 2021.89

SMA 5023.13

SMA 20017.00

Price vs 50+8.14%

Price vs 200+47.15%

MA stackbullish

50/200 cross—

Supertrendup · 20.53

RSI (14)63

MACD hist0.55

MACD crossbull · 9d

Stoch %K / %D90 / 93

ADX (14)21

+DI / −DI27 / 13

RSI divergence—

MACD divergenceBullish

ATR %+5.97%

ADR %6.49%

52w high29.98

52w low2.93

From 52w high-16.58%

Above 52w low+753.58%

New 52w highNo

SqueezeOff

Bollinger width36.29%

%B0.89

Donchian pos90.17%

Donchian high25.74

Donchian low18.36

AVWAP (52w high)24.18

vs AVWAP high+3.44%

AVWAP (52w low)17.28

vs AVWAP low+44.70%

OBV trendUp

Chaikin MF (20)0.04

Today vs 20d1.21×

Avg vol (14d)1.47M

Avg vol (20d)1.36M

Avg $ vol (20d)29.78M

Market cap2.13B

RS 3m (vs SPY)-4.54%

RS 6m (vs SPY)+112.37%

RS line new highNo

Trend template7/8

Technical rank91.4

1 week+8.50%

1 month+12.00%

3 months+0.81%

6 months+123.70%

1 year+730.90%

YTD+179.29%

P/E-8.74

P/B3.75

P/S88.42

P/FCF-5.74

EPS-2.86

Div yield—

ROE-42.91%

ROA-36.23%

Debt/Eq—

Current7.51

EV/EBITDA-4.58

Gross margin—

Net margin—

Rev growth—

EPS growth17.30%

Price target40.67

Target upside62.61%

Analyst ratingBuy

Institutional97.47%

Ent. value2.06B

Revenue1.74M

Net income-93.05M

Gross profit—

Free cash flow-370.18M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out123.43M

Employees227

ListedFri, Jun 28, 2024

Free float71.06M

Float %57.7%

Short interest11.07M

Days to cover13.0d

Short volume49.8%

Squeeze score66 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.74 vs −$0.79

Last surprise+6.3% beat

Setup gradeB

Conviction61 / 100

Pattern quality—

Tech rank91.4 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance25.95

Support18.99

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ALMS

All disclosures →

No recent disclosed trades by Congress in ALMS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ALMS · 2 buys · 2 sells

Insider	Side	Shares	Value	Traded	Filed
Drappa Jorn Chief Medical Officer · Common Stock · 2026-05-22	Exercise	11.32K	$100K	2026-05-22	2026-05-27
Drappa Jorn Chief Medical Officer · Stock Option (Right to Buy) · 2026-05-22	Exercise	15.54K	$0	2026-05-22	2026-05-27
Drappa Jorn Chief Medical Officer · Stock Option (Right to Buy) · 2026-05-22	Exercise	11.32K	$0	2026-05-22	2026-05-27
Drappa Jorn Chief Medical Officer · Common Stock · 2026-05-22	Exercise	15.54K	$79K	2026-05-22	2026-05-27

SEC filings

EDGAR filings in ALMS

EDGAR →

No recent SEC filings on file for ALMS.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.